SKYSIS PROMOTES DAWN RICH TO MANAGING DIRECTOR

Skysis, LLC, a specialized consulting firm that provides in-depth strategic insights and commercial execution to biopharmaceutical companies, is pleased to announce the promotion of Dawn Rich to Managing Director.

Rich joined Skysis in 2015 to launch the Global Pricing & Market Access services. She has rapidly grown the practice, which includes market access lifecycle planning; pricing and distribution strategy; corporate, portfolio and product value propositions; segment strategy and planning; foundation and patient access planning and strategies; and managed care market research analysis and recommendations.

Before joining Skysis, Rich was with Genentech for 11 years in director-level positions within the managed care customer operations and commercial training and development teams. She also spent 8 of her 10 years while at Amgen planning and implementing national and regional managed care strategies. She is experienced across a number of therapeutic categories, including endocrinology, oncology, pediatrics, rheumatology and HIV.

As a respected thought leader, Rich has presented at the Specialty Pharmaceutical Reimbursement and Market Access Conference. At the upcoming 2017 Asembia Conference, she will moderate a panel presentation titled “The Variables of Value Proposition,” tapping into a panel of payer experts who will discuss how clinical + economic + contracting all play into creating effective partnerships and strong brand value.

Rich received an MBA from the University of San Francisco and a BS in Pharmacy from Duquesne University.

About Skysis Global Pricing & Market Access

Skysis GPMA team members average 15+ years of experience in the Market Access arena, specializing in the areas of Business Planning, Strategy & Marketing, Pricing & Distribution, and Market Access Insights. From strategic direction to tactical implementation, we partner with our clients to help them achieve a higher level of success.

About Skysis, LLC

Skysis is a team of experienced commercial professionals that provides in-depth strategic insights and commercial execution to biopharmaceutical companies. Through proven processes and an extensive network of subject matter experts, Skysis delivers specialized capabilities in the areas of New Product Planning, Pricing & Market Access, Strategic Advisory Services, Market Insights and Brand Management. Skysis has more than 85 professionals in the US with a footprint and capabilities that extend across Europe and Asia/Pac. The company’s mission is to partner with its clients to help them achieve a higher level of success.